Hua Medicine (Shanghai) Ltd.
HUMDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,074,448 | $3,120,503 | $3,000,479 | $4,257,444 |
| - Cash | $1,139,753 | $1,460,824 | $490,632 | $675,238 |
| + Debt | $300,179 | $167,754 | $97,582 | $71,528 |
| Enterprise Value | $234,874 | $1,827,433 | $2,607,429 | $3,653,734 |
| Revenue | $255,892 | $76,610 | $17,599 | $0 |
| % Growth | 234% | 335.3% | – | – |
| Gross Profit | $124,724 | $37,374 | $7,689 | $0 |
| % Margin | 48.7% | 48.8% | 43.7% | – |
| EBITDA | -$206,952 | -$167,089 | -$168,063 | -$309,686 |
| % Margin | -80.9% | -218.1% | -955% | – |
| Net Income | -$250,144 | -$211,234 | -$203,766 | -$330,951 |
| % Margin | -97.8% | -275.7% | -1,157.8% | – |
| EPS Diluted | -0.25 | -0.22 | -0.21 | -0.34 |
| % Growth | -13.6% | -4.8% | 38.2% | – |
| Operating Cash Flow | -$417,966 | $889,367 | -$230,114 | -$272,981 |
| Capital Expenditures | -$3,860 | -$9,842 | -$27,467 | -$66,891 |
| Free Cash Flow | -$421,826 | $879,525 | -$257,581 | -$339,872 |